title: Improved clinical outcome of patients with Candida bloodstream infections through direct consultation by infectious diseases physicians in a Japanese university hospital.
abstract: OBJECTIVE
  To examine whether intervention by infectious diseases physicians (IDPs) in the treatment decisions that emphasize adequate antifungal treatment and early removal of central venous catheter for patients with Candida bloodstream infection (BSI) improves prognosis.
  
  
  METHODS
  Retrospective cohort study of patients with Candida BSI, comparing the prognosis of patients before and after the start of the intervention.
  
  
  METHODS
  A 1,240-bed, tertiary care university hospital.
  
  
  METHODS
  Forty patients with Candida BSI during a 2-year period, from January 2001 to December 2002, were included in the study. Twenty-three patients in the first year after the start of intervention by IDPs (intervention group) were compared with 17 patients in the first year before the start of the IDP intervention (baseline group).
  
  
  METHODS
  In January 2002, a total of 5 IDPs at Kyoto University Hospital gave unsolicited recommendations on antifungal treatment and advised all physicians treating inpatients who had Candida BSI to remove the central venous catheter.
  
  
  RESULTS
  No significant difference was seen between the 2 groups in patients' clinical background, species, and fluconazole susceptibility of the causative organisms. The 30-day survival rate was significantly better in the intervention group (18 [78%] of 23 patients) than in the baseline group (7 [44%] of 16 patients; P=.04 by Fisher's exact test). More patients in the intervention group than in the baseline group received appropriate antifungal therapy (81% vs 50%) and had their central venous catheter removed at an appropriate time (95% vs 81%).
  
  
  CONCLUSIONS
  The introduction of an active system of IDP consultation for every case of Candida BSI in our hospital substantially improved patient outcomes.
authors.affiliation: Department of Infection Control and Prevention, Kyoto University Graduate School of Medicine, Kyoto, Japan. stakakr@kuhp.kyoto-u.ac.jp
authors.forename: Shunji
authors.initials: S
authors.lastname: Takakura
authors.forename: Naoko
authors.initials: N
authors.lastname: Fujihara
authors.forename: Takashi
authors.initials: T
authors.lastname: Saito
authors.forename: Terumi
authors.initials: T
authors.lastname: Kimoto
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Ito
authors.forename: Yoshitsugu
authors.initials: Y
authors.lastname: Iinuma
authors.forename: Satoshi
authors.initials: S
authors.lastname: Ichiyama
mesh_terms: D000328:Adult; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002175:Candida / Q000145:classification* / Q000302:isolation & purification; D002177:Candidiasis / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D005260:Female; D006785:Hospitals, University; D006801:Humans; D007564:Japan; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012017:Referral and Consultation; D012189:Retrospective Studies
chemical_list: D000935:Antifungal Agents